Initial Combination of Gemigliptin and Metformin on Microbiota Change

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to investigate gut microbiota change and glucose lowering effect of initial combination therapy of gemigliptin and metformin compared to glimepiride and metformin in obese patients with type 2 diabetes.
Epistemonikos ID: 56fd1410f897e456db3ced3e707f90a6911c82b0
First added on: May 12, 2024